Results 171 to 180 of about 6,346 (209)

Altitude sickness.

Clinical evidence, 2005
Up to half of people who ascend to heights above 2500 m may develop acute mountain sickness, pulmonary oedema, or cerebral oedema, with the risk being greater at higher altitudes, and with faster rates of ascent.We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of interventions to prevent, and ...
Marc Moritz, Berger, Peter, Bärtsch
  +9 more sources

Altitude sickness and acetazolamide

BMJ, 2018
### What you need to know A 25 year old man plans to trek to Everest Base Camp (5545 m) in Nepal for charity. He asks you for a prescription of acetazolamide to prevent mountain sickness. For most people, mountain sickness is a self limiting illness, but it can become life threatening.
Jonathan, Williamson   +2 more
openaire   +2 more sources

Altitude sickness.

Australian family physician, 1990
Altitude sickness is a clinical syndrome that occurs with abrupt ascents to altitudes of 3000 metres and above. Symptoms include headache, malaise, fatigue, dizziness, anorexia, nausea and vomiting, and oliguria. At higher altitudes more severe illness resulting from pulmonary oedema or cerebral oedema can occur.
openaire   +1 more source

Pharmacological control of altitude sickness

Trends in Pharmacological Sciences, 1991
Acute mountain sickness has long been recognized as a potentially life-threatening condition afflicting otherwise healthy individuals who ascend rapidly to high altitude, where the partial pressure of oxygen in the air is reduced. The symptoms of acute mountain sickness are probably a consequence of disturbances in fluid balance brought about by severe
openaire   +2 more sources

Home - About - Disclaimer - Privacy